Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ahlstrom-Munksjö Oyj: Change in the holding of Spa Holdings 3 Oy

AHLSTROM-MUNKSJÖ OYJ STOCK EXCHANGE RELEASE February 10, 2021 at 18:10 EET Ahlstrom-Munksjö Oyj has today received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from Bain Capital Investors, LLC, the ultimate controlling entity of Spa Holdings 3 Oy. According to the notification, the shareholding of Spa Holdings 3 Oy in Ahlstrom-Munksjö Oyj has exceeded the threshold of 90 percent on February 10, 2021, to 104,232,535 shares (from 80.58 percent to 90.12 percent). Ahlstrom-Munksjö Oyj’s registered total number of shares and voting rights of 115,

#21-53 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-52 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Saga Pure ASA: share capital increase registered

Reference is made to the stock exchange notice from Saga Pure ASA (the "Company") dated 28 January 2021 regarding completion of three different subsequent offerings (the "Subsequent Offerings"). In the Subsequent Offerings, a total of 9,728,592 new shares were allocated to subscribers. The share capital increase pertaining to the Subsequent Offerings has now been registered with the Norwegian Register of Business Enterprises. The new registered share capital of the Company is NOK 4,788,784.23 divided by 478,878,423 shares, each with a par value of NOK 0.01. The new shares will be

Panoro Energy: Notice of Extraordinary General Meeting on 3 March 2021

Oslo, 10 February 2021 – Panoro Energy ASA, (“Panoro” or the “Company” with OSE Ticker: PEN) today announces that the Extraordinary General Meeting (“EGM”) for the Company has been scheduled for 3 March 2021 and will be held at 09:00 a.m. CET at Panoro’s offices located at Advokatfirmaet Schjødt, Ruseløkkveien 14, Oslo, Norway. The key item on the agenda is the approval of New Shares to be issued following successful completion of the Private Placement that has been announced earlier today on 10 February 2021. The formal notice of the EGM is attached to this release and can also be

Safe at Sea register a fully owned subsidiary company in the Mediterranean area

Safe at Sea AB has been informed that the Registration Office in Italy has approved the formation of a fully owned subsidiary company in Italy with the company name Safe At Sea srl.The registration process of an Italian company for business and marketing activities in the Mediterranean area has been planned for a long time, but as we reported during 2020, the decision and process has been postponed and adjusted according to the corona pandemic impact. With the registered Italian company the ambition is to further strengthen our position and presence in the Mediterranean area and in the

Two partially owned subsidiaries of Misen Energy AB (publ) received compensation from JSC Ukrgasvydobuvannya

On 10 February 2021, Misen Enterprises AB received US dollars 47,060,537.16 (approx. kSEK 393,426) and LLC Karpatygaz received UAH 1,001,242.74 (approx. kSEK 295) from JSC Ukrgasvydobuvannya in accordance with the ruling of the Kyiv Court of Appeal of 5 January 2021. This compensation is after taxes applicable to Misen Enterprises AB in Ukraine. As previously reported, JSC Ukrgasvydobuvannya was entitled to withhold a tax on non-resident income for 15% of the compensation to Misen Enterprises AB (UAH 236,113,788, approx. KSEK 75,845) and pay the withheld amount to the budget of Ukraine.

Invitation to conference/online presentation call in connection due to Year-end report, 2020

SaltX Technology Holding invites to conference call/online presentation February 17, 2021, at 10:00 CEST (Swedish presentation) and at 11:00 CEST (English presentation). CEO Carl-Johan Linér presents the report together with Harald Bauer, CFO. Thereafter, the opportunity is given to ask questions.The Year-end report will  be published  on February 17 at about 08:00.    How  to participate:   10:00 CEST (Swedish presentation)    - Via Computer: https://zoom.us/j/93539377045 - By phone: +46 850 539 728  -  Enter Meeting ID: 935 3937 7045 -

NRC Group ASA - Invitation to presentation of Q4 2020 results

NRC Group ASA will release its financial results for fourth quarter 2020, on Wednesday 17 February at 07:00 AM (CET). The presentation will be held as a webcast in English which will be available from 07.00 AM (CET). The webcast will be followed by a Q&A-session at 10.00 AM (CET), and investors, analysts and journalists are welcome to participate. The presentation will be held by CEO Henning Olsen and CFO Dag Fladby. Participants dial-in numbers: NO: +47 2350 0296 SE: +46 (0)8 5065 3942 FI: +358 (0)9 7479 0404 DK: +45 3515 8121 UK: +44 (0)330 336 9411 US: +1

Swedavia's Year-End Report 2020: Historic loss due to pandemic - despite early, forceful measures

Swedavia's Year-End Report for 2020 is dominated by the historic impact of the Covid-19 pandemic on air travel and Swedavia's own operations. Swedavia entered the crisis with a good financial position and carried out drastic measures, but is nonetheless reporting a pre-tax loss of almost 1.7 billion Swedish kronor. The pandemic has also dominated the start of 2021, with very low passenger levels."The conditions for running commercial airport operations have been completely upended by the impact of the pandemic. Our passengers disappeared nearly overnight in mid-March, and we lost a total of

Olvi plc: Notification of Manager’s Transactions

Olvi plc                Stock Exchange Release 10 FEB 2021 AT 4.30 pm Olvi plc: Notification of Manager’s Transactions Person subject to the notification requirementName: Akkel PeepPosition: Other Senior ManagementIssuerName: Olvi plcLEI: 7437003NX7WWVRT6AJ55Initial notificationReference number: 7437003NX7WWVRT6AJ55_20210210082911_3 Transaction detailsTransaction date: 9.2.2021Venue: Outside a trading venueNature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE OF REMUNERATIONInstrument: ShareISIN: FI0009900401Volume: 1 000                Unit price: 0.

Elkem acquires new plant in France to accelerate growth in specialised silicones

Elkem has signed an agreement to acquire a brand-new plant near Lyon in France, custom-designed for producing highly specialised organo-functional silicones (OFS). The acquisition underpins Elkem’s strategy of growth and specialisation.The purchase price is in the low double-digit millions of euros, and production is expected by the end of the year. “With this acquisition, Elkem continues to deliver on our growth and specialisation strategy. This new plant will enable us to more quickly extend our offerings within advanced high value products for attractive specialty markets, further

EQT Private Equity invests in CYE, an Israel-based global cybersecurity leader

· EQT Private Equity makes a USD ~100 million growth investment in CYE, an Israel-based leader in cybersecurity and cyber optimization solutions  · CYE helps companies reclaim control of their cybersecurity by mimicking real-world attacks on their digital infrastructure, developing optimized risk prioritization and mitigation plans – making today’s societies and digital environments a safer place  · EQT will leverage its global network and expertise in scaling software and cybersecurity companies to accelerate CYE’s go-to market and product investments, geographical expansion and

Össur will be carbon neutral in 2021

Company On Track to Achieve Environmental Milestone During 50[th] Anniversary YearREYKJAVIK, Iceland, February 10, 2021 – Össur (Nasdaq:OSSR), a global leader in the orthotics and prosthetics (O&P) industry with a rich history of ground-breaking innovations, announced today that the company will be carbon neutral in 2021, its 50[th] anniversary year. Originally founded in February 1971, the company has demonstrated successful growth since its initial public listing in 1999. A leading innovator in the prosthetics and bracing and supports field, Össur has been actively working towards a

SOTKAMO SILVER AB: Q4/2020 RELEASE AND WEB CAST

Press release: Stockholm, February 10, 2021 15:00 CETSotkamo Silver AB will release Q4/2020 results on February 17, 2021 around 08:45 CET. The webcast to the investors will be held on February 17, 2021, at 14:00 Finnish time via a Teams-meeting. You can register for the meeting on the company's website at: www.silver.fi/fi/sijoittajat/ilmoittaudu We will send registration instructions and a link to the event to those who have registered before the event. Please, make your registration by February 16, 2021. The presentation will be in Finnish, and the material is in English. The

Medivir enters into licensing agreement with Ubiquigent for preclinical program USP7

Stockholm, Sweden— Medivir AB (Nasdaq Stockholm: MVIR) announced today that it had entered into a license agreement with Ubiquigent Limited (Ubiquigent) for Medivir’s preclinical USP7 research program. Under the terms of the agreement, Medivir has granted Ubiquigent an exclusive worldwide license to develop and commercialize the program including all associated compounds across any therapeutic indication(s) in return for agreed revenue share upon successful development or commercialization by Ubiquigent. Ubiquitin specific peptidase 7 (USP7) is a deubiquitylating (DUB) enzyme that has

Cint publishes prospectus and announces price range for its initial public offering on Nasdaq Stockholm

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, JAPAN, CANADA, AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE.For complete press release please refer to: https://investors.cint.com/en/ipo For more information, please contact: Joakim Andersson, CFOTel: +46 760 44 8330Email: joakim.andersson@cint.com Patrik Linzenbold, Head of IRTel: +46 708 252

Year-end report 2020: Strong growth in sales and profit

Fourth quarter 2020: · Sales increased to SEK 2,487 million (2,296) · Operating profit (EBITA) rose to SEK 283 million (249) · Profit after tax was SEK 211 million (206) · Diluted earnings per share increased to SEK 7.87 (7.75) · Cash flow after investments was SEK 211 million (SEK 601 million excl. acquisitions) · The equity/assets ratio was 43% (48), with net financial liabilities of SEK 298 million (net assets of SEK 666 million) · The Board proposes a dividend of SEK 16.00 (0.00) per share · The Board proposes a 10:1 share split “Nolato continued to perform

OncoZenge has been approved for listing on Nasdaq First North Growth Market

OncoZenge AB (publ) has today obtained approval from Nasdaq Stockholm for admission to trading on Nasdaq First North Growth Market. The first day of trading in OncoZenge's shares will be on Friday, February 12, 2021.THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY

NOTICE OF EXTRAORDINARY GENERAL MEETING OF ACROUD AB (PUBL)

This is a translation of the Swedish original. In case of discrepancies between this English translation and the Swedish original, the latter shall prevail. Press Release10 February 2021The shareholders of Acroud AB (publ), 556693-7255 (”Company”), are hereby given notice of the Extraordinary General Meeting on Monday 1 March 2021 to be held by postal voting only. By reason of the transmission of the coronavirus, the board of directors has decided that the extraordinary general meeting (EGM) will be held by postal voting ahead of the meeting, in accordance with temporary legislation.

Invitation to the presentation of John Mattson’s year-end report for 2020, on 24 February at 10:00 a.m. (CET)

Invitation by John Mattson to the teleconference and webcast on 24 February at 10:00 a.m. (CET) being held in conjunction with the publication of the company’s year-end report at 8:00 a.m. (CET) the same date.Investors, asset managers, equity analysts, the press and other stakeholders are invited to participate in the conference, where CEO Siv Malmgren and CFO Maria Sidén will present the year-end report for 2020. No advance notice of attendance is required. Following the presentation, it will be possible to ask questions. The presentation starts at 10:00 a.m. (CET) and will be held in

Elekta’s ProKnow to help standardize radiotherapy for veterans

Cloud-based ProKnow will enable peer review across Veterans Affairs networkATLANTA, February 10, 2021 – Elekta announced today that the United States Department of Veterans Affairs (VA) National Radiation Oncology Program is poised to pair its major radiotherapy quality program with Elekta’s (EKTA-B.ST) ProKnow , a web browser-based cloud solution that centralizes radiotherapy data in a secure scalable platform accessible to all 41 of the VA’s radiation oncology facilities nationwide. “ProKnow is designed to give caregivers the ability to evaluate massive

Orexo starts to test modia™ on patients in collaboration with ApexB.io and Magellan Rx Management

·The Covid-19 pandemic has highlighted the urgent need for additional resources to prevent overdose deaths, which have reached an all-time high[[[1]]] · modia™ can help those with opioid use disorder by providing access to quality, evidence-based interventions and behavioral health servicesMORRISTOWN, NJ, US, February 10, 2021: Orexo, a Swedish pharmaceutical company,will collaborate with ApexB.io and Magellan Rx Management to further research on the use of modia™, a digital therapeutic designed for individuals with opioid use disorder (OUD), by establishing a novel, real-world

Arcus ASA: Invitation to presentation of Arcus' fourth quarter 2020 results, Wednesday 17 February

Arcus will report its fourth quarter 2020 results on Wednesday 17 February 2021 at 08.00 CET. The quarterly report and the presentation material will be available at https://www.arcus.no/en/investor. As a consequence of the Covid-19 pandemic, there will not be a physical presentation of the results. Instead, we invite to a live Teams-meeting Wednesday 17 February at 08.00 CET. You can join the presentation here 

There are no items matching the current filter
There are no more items matching the current filter
Back to top